Tego Cyber (TGCB) 10-Q 17 May 24 2024 Q3 Quarterly report Financial data

Cover

Cover - shares	9 Months Ended
	Mar. 31, 2024	May 17, 2024
Cover [Abstract]
Entity Registrant Name	TEGO CYBER INC.
Entity Central Index Key	0001815632
Document Type	10-Q
Amendment Flag	false
Current Fiscal Year End Date	--06-30
Entity Small Business	true
Entity Shell Company	false
Entity Emerging Growth Company	true
Entity Current Reporting Status	Yes
Document Period End Date	Mar. 31, 2024
Entity Filer Category	Non-accelerated Filer
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2024
Entity Ex Transition Period	false
Entity Common Stock Shares Outstanding		76,090,356
Document Quarterly Report	true
Document Transition Report	false
Entity File Number	000-56370
Entity Incorporation State Country Code	NV
Entity Tax Identification Number	84-2678167
Entity Address Address Line 1	8565 South Eastern Avenue
Entity Address Address Line 2	Suite 150
Entity Address City Or Town	Las Vegas
Entity Address State Or Province	NV
Entity Address Postal Zip Code	89123
City Area Code	855
Local Phone Number	939-0100
Entity Interactive Data Current	Yes

CONDENSED BALANCE SHEETS

CONDENSED BALANCE SHEETS - USD ($)	Mar. 31, 2024	Jun. 30, 2023
Current assets
Cash	$ 69,284	$ 181,246
Prepaid expenses (Note 5)	13,218	30,226
Total current assets	82,502	211,472
Other assets	25,000	25,000
TOTAL ASSETS	107,502	236,472
Accounts payable & accrued liabilities	480,787	129,273
Deferred revenue	33,962	0
Notes payable (Note 9)	1,020,000	891,694
TOTAL LIABILITIES	1,534,749	1,020,697
Common shares 100,000,000 shares authorized $0.001 par value 71,068,356 shares issued and outstanding at March 31, 2024 and 47,343,282 shares at June 30, 2023	71,068	47,343
Additional paid in capital	20,777,675	14,054,838
Accumulated deficit	(22,275,990)	(14,886,676)
TOTAL SHAREHOLDERS' EQUITY (DEFICIT)	(1,427,247)	(784,495)
TOTAL LIABILITIES & SHAREHOLDERS' EQUITY (DEFICIT)	$ 107,502	$ 236,472

CONDENSED BALANCE SHEETS (Paren

CONDENSED BALANCE SHEETS (Parenthetical) - $ / shares	Mar. 31, 2024	Jun. 30, 2023
CONDENSED BALANCE SHEETS
Common stock, par value	$ 0.001	$ 0.001
Common stock, authorized	100,000,000	100,000,000
Common stock, issued	71,068,356	47,343,282
Common stock, outstanding	71,068,356	47,343,282

CONDENSED STATEMENTS OF OPERATI

CONDENSED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023
REVENUE
Subscription revenue	$ 14,231	$ 0	$ 24,962	$ 0
TOTAL REVENUE	0	0	24,962	0
OPERATING EXPENSES
General & administrative	652,640	2,178,610	2,469,866	3,863,450
Professional fees	27,530	379,264	104,230	532,444
Sales & marketing	15,516	69,228	73,109	305,416
TOTAL OPERATING EXPENSES	695,686	2,627,102	2,647,205	4,701,310
NET OPERATING LOSS	(681,455)	(2,627,102)	(2,622,243)	(4,701,310)
OTHER INCOME (EXPENSE)
Accretion expense	0	(146,461)	(8,306)	(682,812)
Interest expense	0	(29,990)	0	(64,709)
Financing fees	(380,708)	(2,050,804)	(4,758,765)	(2,050,804)
TOTAL OTHER INCOME (EXPENSE)	(380,708)	(2,227,255)	(4,767,071)	(2,798,325)
NET LOSS	$ (1,062,163)	$ (4,854,357)	$ (7,389,314)	$ (7,499,635)
BASIC AND DILUTED LOSS PER COMMON SHARE	$ (0.02)	$ (0.14)	$ (0.13)	$ (0.26)
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING	66,307,419	34,355,914	57,923,682	29,296,426

CONDENSED STATEMENTS OF CHANGES

CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDERS EQUITY (DEFICIT) (Unaudited) - USD ($)	Total	Common Stock [Member]	Additional Paid-In Capital	Subscription Receivable	Retained Earnings (Accumulated Deficit)
Balance, shares at Jun. 30, 2022		25,508,044
Balance, amount at Jun. 30, 2022	$ 463,273	$ 25,508	$ 4,586,049	$ 0	$ (4,148,284)
Shares issued as transaction costs for notes payable, shares		3,766,666
Shares issued as transaction costs for notes payable, amount	456,372	$ 3,767	452,605	0	0
Shares issued for services, shares		3,775,000
Shares issued for services, amount	1,937,500	$ 3,775	1,933,725	0	0
Shares issued from private placements, shares		8,170,000
Shares issued from private placements, amount	817,000	$ 8,170	808,830	0	0
Shares issued for debts, shares		45,000
Shares issued for debts, amount	9,000	$ 45	8,955	0	0
Share-based compensation	1,536,980	0	1,536,980	0	0
Warrants issued with notes payable	2,137,244	0	2,137,244	0	0
Net loss	(7,499,635)	$ 0	0	0	(7,499,635)
Share-based compensation	1,536,980
Balance, shares at Mar. 31, 2023		41,264,710
Balance, amount at Mar. 31, 2023	(142,266)	$ 41,265	11,464,388	0	(11,647,919)
Balance, shares at Dec. 31, 2022		27,816,377
Balance, amount at Dec. 31, 2022	(245,765)	$ 27,816	6,519,981	0	(6,793,562)
Shares issued as transaction costs for notes payable, shares		2,233,333
Shares issued as transaction costs for notes payable, amount	223,354	$ 2,234	221,120	0	0
Shares issued for services, shares		3,500,000
Shares issued for services, amount	1,800,000	$ 3,500	1,796,500	0	0
Shares issued from private placements, shares		7,670,000
Shares issued from private placements, amount	767,000	$ 7,670	759,330	0	0
Shares issued for debts, shares		45,000
Shares issued for debts, amount	9,000	$ 45	8,955	0	0
Warrants issued with notes payable	1,827,451	0	1,827,451	0	0
Net loss	(4,854,357)	0	0	0	(4,854,357)
Share-based compensation	331,051	$ 0	331,051	0	0
Balance, shares at Mar. 31, 2023		41,264,710
Balance, amount at Mar. 31, 2023	(142,266)	$ 41,265	11,464,388	0	(11,647,919)
Balance, shares at Jun. 30, 2023		47,343,282
Balance, amount at Jun. 30, 2023	(784,495)	$ 47,343	14,054,838	0	(14,886,676)
Shares issued as transaction costs for notes payable, shares		7,033,334
Shares issued as transaction costs for notes payable, amount	2,356,705	$ 7,033	2,349,672	0	0
Shares issued for services, shares		2,900,000
Shares issued for services, amount	612,749	$ 2,900	609,849	0	0
Shares issued from private placements, shares		9,770,000
Shares issued from private placements, amount	612,000	$ 9,770	602,230	0	0
Warrants issued with notes payable	1,883,852	0	1,883,852	0	0
Net loss	(7,389,314)	$ 0	0	0	(7,389,314)
Share-based compensation	1,175,369
Shares issued for debt settlements, shares		1,271,740
Shares issued for debt settlements, amount	63,587	$ 1,272	62,315	0
Share based compensation, shares		2,750,000
Share based compensation, amount	681,959	$ 2,750	679,209	0	0
Share based compensation - options	493,410	0	493,410	0	0
Warrant re-price for note extension	$ 42,300	$ 0	42,300	0	0
Balance, shares at Mar. 31, 2024	9,000,000	71,068,356
Balance, amount at Mar. 31, 2024	$ (1,427,247)	$ 71,068	20,777,675	0	(22,275,990)
Balance, shares at Dec. 31, 2023		61,446,616
Balance, amount at Dec. 31, 2023	(1,344,795)	$ 61,446	19,857,586	(50,000)	(21,213,827)
Shares issued for services, shares		1,150,000
Shares issued for services, amount	107,149	$ 1,150	105,999	0	0
Shares issued from private placements, shares		4,900,000
Shares issued from private placements, amount	295,000	$ 4,900	240,100	50,000	0
Net loss	(1,062,163)	$ 0	0	0	(1,062,163)
Shares issued for debt settlements, shares		1,271,740
Shares issued for debt settlements, amount	63,587	$ 1,272	62,315	0
Share based compensation, shares		2,300,000
Warrant re-price for note extension	42,300	$ 0	42,300	0	0
Share-based compensation, amount	353,226	2,300	350,926	0	0
Share-based compensation - options	$ 118,449	$ 0	118,449	0	0
Balance, shares at Mar. 31, 2024	9,000,000	71,068,356
Balance, amount at Mar. 31, 2024	$ (1,427,247)	$ 71,068	$ 20,777,675	$ 0	$ (22,275,990)

CONDENSED STATEMENTS OF CASH FL

CONDENSED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)	9 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss for the period	$ (7,389,314)	$ (7,499,635)
Adjustments to reconcile net loss to net cash used in operating activities
Shares issued for services	612,749	1,937,500
Interest on short term debt	0	29,990
Amortization and depreciation	0	30,862
Accretion expense	8,306	682,812
Financing fees on settlement of default and extension	4,282,857	2,050,804
Penalty on debt	170,000	0
Share-based compensation	1,175,369	1,536,980
Changes in operating assets and liabilities:
Accounts receivable	0	1,150
Prepaid expenses	17,008	13,627
Accounts payable and accrued liabilities	415,101	26,692
Deferred revenue	33,962	0
NET CASH USED IN OPERATING ACTIVITIES	(673,962)	(1,189,218)
CASH FLOWS FROM INVESTING ACTIVITIES
Software	0	(244,151)
NET CASH USED IN INVESTING ACTIVITIES	0	(244,151)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from shares issued	612,000	817,000
Repayment of notes payable	(64,000)	0
Cash received from issuance of notes payable	14,000	725,000
NET CASH PROVIDED BY FINANCING ACTIVITIES	562,000	1,542,000
NET INCREASE (DECREASE) IN CASH	(111,962)	108,631
CASH AT BEGINNING OF THE PERIOD	181,246	47,742
CASH AT END OF THE PERIOD	69,284	156,373
SUPPLEMENTAL DISCLOSURE OF CASH FLOWS INFORMATION
Cash paid for interest	30,990	12,666
Income taxes	0	0
NON-CASH TRANSACTIONS
Settlement of accounts payable	$ 63,587	$ 0

ORGANIZATION AND DESCRIPTION OF

ORGANIZATION AND DESCRIPTION OF BUSINESS	9 Months Ended
	Mar. 31, 2024
ORGANIZATION AND DESCRIPTION OF BUSINESS
ORGANIZATION AND DESCRIPTION OF BUSINESS	NOTE 1 – ORGANIZATION AND DESCRIPTION OF BUSINESS Tego Cyber Inc. is an early-stage company which was incorporated in the State of Nevada on September 6, 2019. Our year end is June 30. We are a development stage enterprise. We are engaged in the business of the development and commercialization of innovative cybersecurity applications that help enterprises reduce risk, remediate cyber-attacks, and protect intellectual property and data. Our principal office is located at 8565 South Eastern Avenue, Suite 150, Las Vegas, Nevada, 89123. Our telephone number is (855) 939-0100 and our general e-mail contact is info tegocyber.com. Our website can be viewed at www.tegocyber.com.

BASIS OF PRESENTATION

BASIS OF PRESENTATION	9 Months Ended
	Mar. 31, 2024
BASIS OF PRESENTATION
BASIS OF PRESENTATION	NOTE 2 – BASIS OF PRESENTATION The accompanying audited financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“US GAAP”). In the opinion of management, the financial statements include all adjustments of a normal recurring nature necessary for a fair statement of the results for the period presented. The accompanying financial statements have been prepared to present the balance sheets, the statements of operations, statements of changes in shareholders’ equity and the statements of cash flows of the Company for the nine month period ended March 31, 2024 and 2023. The accompanying audited financial statements have been prepared in accordance with US GAAP using Company-specific information where available and allocations and estimates where data is not maintained on a Company-specific basis within its books and records. Due to the allocations and estimates used to prepare the financial statements, they may not reflect the financial position, cash flows and results of operations of the Company in the future or its operations, cash flows and financial position. The preparation of financial statements in accordance with US GAAP requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities known to exist as of the date the financial statements are published, and the reported amounts of revenues and expenses during the reporting period. Uncertainties with respect to such estimates and assumptions are inherent in the preparation of the Company’s financial statements; accordingly, it is possible that the actual results could differ from these estimates and assumptions and could have a material effect on the reported amounts of the Company’s financial position and results of operations.

GOING CONCERN UNCERTAINTY

GOING CONCERN UNCERTAINTY	9 Months Ended
	Mar. 31, 2024
GOING CONCERN UNCERTAINTY
GOING CONCERN UNCERTAINTY	NOTE 3 – GOING CONCERN UNCERTAINTY The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the normal course of the business. The Company has incurred material losses from operations and has an accumulated deficit. As of March 31, 2024, the Company had a working capital deficit of $1,452,247. For the nine months ended March 31, 2024, the Company sustained net losses of $7,389,314 and generated negative cash flows from operations of $673,962. These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern. The financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that may be necessary should the Company be unable to continue as a going concern. These adjustments could be material. The Company’s continuation as a going concern is contingent upon its ability to earn adequate revenues from operations and to obtain additional financing. There is no assurance that the Company will be able to obtain such financings or obtain them on favorable terms.

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	9 Months Ended
	Mar. 31, 2024
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 4 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES This summary of significant accounting policies is presented to assist in understanding the financial statements. The financial statements and notes are representations of the Company’s management, who are responsible for their integrity and objectivity. These accounting policies conform to US GAAP and have been consistently applied in the preparation of these financial statements. Basis of Preparation The accompanying financial statements have been prepared to present the balance sheets, the statements of operations, statements of changes in shareholders’ equity and statements of cash flows of the Company for the nine months ended March 31, 2024 and 2023 and have been prepared in accordance with US GAAP. Use of Estimates In preparing financial statements in conformity with US GAAP, management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the dates of the financial statements, as well as the reported amounts of revenues and expenses during the reporting periods. Management makes these estimates using the best information available at the time the estimates are made. However, actual results could differ materially from those estimates. Reclassification Certain prior period amounts have been reclassified to conform to current period presentation. Concentrations of Credit Risk Financial instruments that potentially subject the Company to significant concentrations of credit risk consist principally of cash and accounts receivable. As of March 31, 2024, substantially all of the Company’s cash was held by major financial institutions located in the United States, which management believes are of high credit quality. With respect to accounts receivable, the Company extended credit based on an evaluation of the customer’s financial condition. The Company generally did not require collateral for accounts receivable and maintained an allowance for doubtful accounts of accounts receivable if necessary. Cash Cash consists of cash held at major financial institutions and is subject to insignificant risk of changes in value. Receivables and Allowance for Doubtful Accounts Trade accounts receivable are recorded at net realizable value and do not bear interest. No allowance for doubtful accounts was made during the nine months ended March 31, 2024 and 2023, based on management’s best estimate of the amount of probable credit losses in accounts receivable. The Company evaluates its allowance for doubtful accounts based upon knowledge of its customers and their compliance with credit terms. The evaluation process includes a review of customers’ accounts on a regular basis. The review process evaluates all account balances with amounts outstanding for more than 60 days and other specific amounts for which information obtained indicates that the balance may be uncollectible. As of March 31, 2024 and 2023, there was no allowance for doubtful accounts and the Company does not have any off-balance-sheet credit exposure related to its customers. Software Software is stated at cost less accumulated amortization and is depreciated using the straight-line method over the estimated useful life of the asset. The estimated useful life of the asset is 5 years. During the three months ended March 31, 2024, all development costs were expensed as incurred as management determined the costs were associated with minor updates and upgrades that did not impact the overall carrying value of the underlying software. Leases The Company determines if an arrangement is a lease at inception. Operating and financing right-of-use assets and lease liabilities are included on the balance sheet. Right-of-use assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Right-of-use assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. The Company uses its incremental borrowing rate, based on the information available at the commencement date, in determining the present value of future lease payments. Right-of-use assets include any prepaid lease payments and exclude any lease incentives and initial direct costs incurred. Operating lease expenses are recognized on a straight-line basis over the term of the lease, consisting of interest accrued on the lease liability and depreciation of the right-of-use asset. The lease terms may include options to extend or terminate the lease is it is reasonably certain the Company will exercise that option. The Company leases its corporate office located at 8565 S. Eastern Ave. #150, Las Vegas, Nevada. The initial lease term is for 12 months commencing on September 8, 2019 after which the term is on a month-to-month basis. After the initial term, the Company may cancel the lease agreement at any time by providing 30 days written notice. The Company has elected the short-term lease practical expedient of 12 months and has not recorded a lease. Fair Value of Financial Instruments Accounting Standards Codification (“ASC”) 820 “Fair Value Measurements and Disclosures”, adopted January 1, 2008, defines fair value, establishes a three-level valuation hierarchy for disclosures of fair value measurement and enhances disclosure requirements for fair value measures. The Company’s financial instruments include cash, current receivables and payables. These financial instruments are measured at their respective fair values. The three levels are defined as follows: Level 1 - inputs to the valuation methodology are quoted prices for identical assets or liabilities in active markets. Level 2 - inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the assets or liability, either directly or indirectly, for substantially the full term of the financial instruments. Level 3 - inputs to the valuation methodology are unobservable and significant to the fair value. For cash, accounts receivable, accounts payable and accrued liabilities and due to related parties, it is management’s opinion that the carrying values are a reasonable estimate of fair value because of the short period of time between the origination of such instruments and their expected realization and if applicable, their stated interest rate approximates current rates available. For convertible debts, the carrying values, excluding any unamortized discounts, approximate the respective fair value. The convertible debts have been discounted to reflect their net present value as of September 30, 2023. The carrying values of embedded conversion features not considered to be derivative instruments were determined by allocating the remaining carrying value of the convertible debt after deducting the estimated carrying value of the liability portion. Estimating fair value for warrants require determining the most appropriate valuation model which is dependent on the terms and conditions of the grant. This estimate requires determining the most appropriate inputs to the valuation model including the expected life of the warrant, volatility, dividend yield, and rate of forfeitures and making assumptions about them. Revenue Recognition We derive revenue from the sale of Tego software subscriptions, and Tego TI intelligence feed subscriptions. We enter into contracts with customers that include promises to transfer various products and services, which are generally capable of being distinct and accounted for as separate performance obligations. Revenue is recognized when the promised goods or services are transferred to customers, in an amount that reflects the consideration allocated to the respective performance obligation. The following table shows our revenue by source for the periods indicated: Three Months Ended March 31, Nine Months Ended March 31, 2024 2023 2024 2023 Software $ 14,231 $ - $ 24,962 $ - $ 14,231 $ - $ 24,962 $ - Nature of Products Our cloud-based offerings include Tego cyber threat detection and correlation software, and threat intelligence data feeds, developed for use by organizations from small to large. These cloud-based offerings provide customers with the right to use the hosted software over the contract period without taking possession of the software and are billed on either a subscription or consumption basis. Revenue related to our cloud-based offerings that are billed on a subscription basis is recognized ratably over the contract period. Revenue related to online offerings that are billed on a consumption basis is recognized when the customer consumes the related service. Deferred Revenue We record deferred revenue when we have entered into a contract with a customer and cash payments are received or due prior to transfer of control or satisfaction of the related performance obligation. Income Taxes The Company uses the asset and liability method of accounting for income taxes pursuant to ASC 740 “Income Taxes”. ASC 740 requires an asset and liability approach for financial accounting and reporting for income taxes and allows recognition and measurement of deferred tax assets based upon the likelihood of realization of tax benefits in future years. Under the asset and liability approach, deferred taxes are provided for the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Valuation allowances are provided for deferred tax assets if it is more likely than not these items will either expire before the Company is able to realize their benefits, or that future deductibility is uncertain. The provision for income taxes represents current taxes payable net of the change during the period in deferred tax assets and liabilities. Earnings (Loss) per Share Basic earnings (loss) per share is computed by dividing income (loss) available to common shareholders by the weighted-average number of common shares outstanding during the period. Diluted earnings (loss) per share is computed similar to basic earnings (loss) per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. If applicable, diluted earnings (loss) per share assume the conversion, exercise or issuance of all common stock instruments unless the effect is to reduce a loss or increase earnings (loss) per share. Dilutive securities are not included in the weighted average number of shares when inclusion would be anti-dilutive. The following table summarizes the securities outstanding and exercisable, (regardless of exercise price) as of March 31, 2024 and 2023 that were excluded from the diluted net loss per share calculation because the effect of including these potential shares was antidilutive due to the Company’s net loss. 2024 2023 Potentially dilutive common share equivalents Options 1,200,000 1,200,000 Warrants 15,171,740 3,914,246 Performance Stock Units 2,700,000 4,000,000 Potentially dilutive shares outstanding 19,071,740 9,114,246 Recently Issued Accounting Pronouncements In August 2020, the FASB issued ASU 2020-06 , Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40)—Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity. Derivatives and Hedging Derivatives and Hedging—Contracts in Entity’s Own Equity Management does not believe that any recently issued, but not yet effective, accounting standards could have a material effect on the accompanying financial statements. As new accounting pronouncements are issued, we will adopt those that are applicable under the circumstances.

PREPAID EXPENSES

PREPAID EXPENSES	9 Months Ended
	Mar. 31, 2024
PREPAID EXPENSES
PREPAID EXPENSES	NOTE 5 – PREPAID EXPENSES Prepaid expense balance as of March 31, 2024 and June 30, 2023 consist of prepaid software development expenses.

SOFTWARE

SOFTWARE	9 Months Ended
	Mar. 31, 2024
SOFTWARE
SOFTWARE	NOTE 6 – SOFTWARE The Company has completed the first version of its technology for integration with the Splunk SIEM platform. That product is now commercially available. The Company is currently developing versions of its application for integration with AWS Security Lake and Elastic SIEM platform. During the year ended June 30, 2023, management identified indicators of impairment on its software and software under development. The indicators consisted of a current and historic cash flow loss from operations. As a result, management performed an impairment test that resulted in the recognition of an impairment loss of $646,271 on the software assets. The Company has no software assets recorded as of March 31, 2024.

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	9 Months Ended
	Mar. 31, 2024
RELATED PARTY TRANSACTIONS
RELATED PARTY TRANSACTIONS	NOTE 7 – RELATED PARTY TRANSACTIONS Related party transactions are measured at the exchange amount, which is the amount of consideration established and agreed to by the related parties. Related parties are natural persons or other entities that have the ability, directly, or indirectly, to control another party or exercise significant influence over the party in making financial and operating decisions. Related parties include other parties that are subject to common control or that are subject to common significant influences. During the nine months ended March 31, 2024, there were transactions incurred between the Company and Shannon Wilkinson, a Director, Chief Technical Officer and former Chief Executive Officer (CEO) of the Company, for gross wages of $15,000 (March 31, 2023 - $90,000) and management fees of $80,504 (March 31, 2023 - $Nil). During the nine months ended March 31, 2024, there were transactions incurred between the Company and Robert Mikkelsen, current CEO and CFO of the Company, for management fees of $47,500 (March 31, 2023 - $Nil). During the nine months ended March 31, 2024, there were transactions incurred between the Company and Earl Johnson, former Chief Financial Officer (CFO) of the Company, for gross wages of $4,500 (March 31, 2023 - $27,000) and management fees of $4,500 (March 31, 2023 - $Nil).

NOTES PAYABLE

NOTES PAYABLE	9 Months Ended
	Mar. 31, 2024
NOTES PAYABLE
NOTES PAYABLE	NOTE 8 – NOTES PAYABLE (convertible only at default) The following table summarizes the Company’s notes payable as of March 31, 2024 and June 30, 2023. Reference Effective Date Annual Interest Rate Maturity Date Principal Outstanding March 31, 2024 Principal Outstanding June 30, 2023 (a) 7/12/22 15 % 6/30/24 $ 335,000 $ 299,926 (b) 7/15/22 15 % 6/30/24 192,500 149,963 (c) 7/18/22 15 % 6/30/24 192,500 149,963 (d) 10/13/22 10 % 6/30/24 150,000 145,923 (e) 10/13/22 10 % 6/30/24 75,000 72,960 (f) 10/13/22 10 % 6/30/24 75,000 72,960 $ 1,020,000 $ 891,694 (a) On July 12, 2022, the Company entered into a securities purchase agreement with a non-related party. Pursuant to this agreement, the Company issued a note payable in the principal amount of $300,000 at $270,000 cash with a $30,000 original issue discount. In connection with this note, the Company paid an additional $27,500 in cash transaction costs, issued 350,000 common shares valued at $178,500 in transaction costs, and issued 500,000 warrants exercisable at $0.25 per share, expiring on July 12, 2027. The warrants were calculated to have a fair value of $249,971 as at July 12, 2022. This note payable is unsecured, bears interest at 10% per annum compounded on the basis of a 365-day year and actual days lapsed payable monthly. The maturity date of this note was extended to June 30, 2024. (b) On July 15, 2022, the Company entered into a securities purchase agreement with a non-related party. Pursuant to this agreement, the Company issued a note payable in the principal amount of $150,000 at $135,000 cash with $15,000 original issue discount. In connection with this note, the Company paid an additional $11,250 in cash transaction costs, issued 175,000 common shares valued at $89,250 in transaction costs, and issued 250,000 warrants exercisable at $0.25 per share, expiring on July 15, 2027. The warrants were calculated to have a fair value of $124,984 as at July 15, 2022. This promissory note is unsecured, bears interest at 10% per annum compounded on the basis of a 365-day year and actual days lapsed payable monthly. The maturity date of this note was extended to June 30, 2024. (c) On July 18, 2022, the Company entered into a securities purchase agreement with a non-related party. Pursuant to this agreement, the Company issued a note payable in the principal amount of $150,000 at $135,000 cash with $15,000 original issue discount. In connection with this note, the Company paid an additional $11,250 in cash transaction costs, issued 175,000 common shares valued at $89,250 in transaction costs, and issued 250,000 warrants exercisable at $0.25 per share, expiring on July 18, 2027. The warrants were calculated to have a fair value of $124,994 as at July 18, 2022. This note payable is unsecured, bears interest at 10% per annum compounded on the basis of a 365-day year and actual days lapsed payable monthly. The maturity date of this note was extended to June 30, 2024. (d) On October 13, 2022, the Company entered into a securities purchase agreement with a non-related party. Pursuant to this agreement, the Company issued a note payable in the principal amount of $150,000 at $135,000 cash with a $15,000 original issue discount. In connection with this note, the Company paid an additional $23,750 in cash transaction costs, issued 416,667 common shares valued at $187,625 in transaction costs, and issued 500,000 warrants exercisable at $0.25 per share, expiring on October 12, 2027. The warrants were calculated to have a fair value of $220,526 as at October 13, 2022. The original maturity date of this note was April 13, 2023, is unsecured, bears interest at 10% per annum compounded on the basis of a 365-day year and actual days lapsed payable monthly. The maturity date of this note was extended to June 30, 2024. (e) On October 13, 2022, the Company entered into a securities purchase agreement with a non-related party. Pursuant to this agreement, the Company issued a note payable in the principal amount of $75,000 at $67,500 cash with $7,500 original issue discount. In connection with this note, the Company paid an additional $5,625 in cash transaction costs, issued 208,333 common shares valued at $93,812 in transaction costs, and issued 250,000 warrants exercisable at $0.25 per share, expiring on October 12, 2027. The warrants were calculated to have a fair value of $110,263 as at October 13, 2022. The original maturity date of this note was, is unsecured, bears interest at 10% per annum compounded on the basis of a 365-day year and actual days lapsed payable monthly. The maturity date of this note was extended to June 30, 2024. (f) On October 13, 2022, the Company entered into a securities purchase agreement with a non-related party. Pursuant to this agreement, the Company issued a note payable in the principal amount of $75,000 at $67,500 cash with $7,500 original issue discount. In connection with this note, the Company paid an additional $5,625 in cash transaction costs, issued 208,333 common shares valued at $93,812 in transaction costs, and issued 250,000 warrants exercisable at $0.25 per share, expiring on October 12, 2027. The warrants were calculated to have a fair value of $110,263 as at October 13, 2022. The original maturity date of this note was April 13, 2023, is unsecured, bears interest at 10% per annum compounded on the basis of a 365-day year and actual days lapsed payable monthly. The maturity date of this note was extended to June 30, 2024. The Company incurred financing expenses totaling $4,520,357 during the nine months ended March 30, 2024 relating to extension fees of its note obligations described in (a-f). The extension fees were paid by issuing 7,033,334 restricted shares and 5 year warrants to purchase 4,500,000 restricted common shares of the Company for $0.25 per share, and were expensed as they were deemed to be extinguishments of the original obligations under ASC 470-50. Additionally, the Company agreed to reduce the exercise price on the warrants to $0.05 and increase the notes payable balances by $170,000 as part of the extensions.

COMMON SHARES

COMMON SHARES	9 Months Ended
	Mar. 31, 2024
COMMON SHARES
COMMON SHARES	NOTE 9 – COMMON SHARES Common Stock At December 31, 2023, the Company’s authorized capital consisted of 100,000,000 of common shares with a $0.001 par value and 59,446,616 shares were issued and outstanding. During the nine months ended March 31, 2024, the Company issued 7,033,334 shares of common stock valued at $2,356,705 (based on market price at the time of the agreement) as part of a default settlement and extension agreement. During the nine months ended March 31, 2024, the Company issued 2,900,000 shares of common stock in exchange for services valued at $612,749 (based on market price at the time of the agreements). During the nine months ended March 31, 2024, the Company issued 9,770,000 shares of common stock to accredited investors for gross cash proceeds of $612,000. During the nine months ended March 31, 2024, the Company issued 2,750,000 shares of common stock as share based compensation valued at $681,959 (based on market price at the time of the agreements). During the nine months ended March 31, 2024, the Company issued 1,271,740 shares of common stock for debt settlement valued at $63,589 (based on $0.05 offering). Warrants The Black Scholes Option Pricing Model assumptions used in the valuation of the warrants are outlined below. The stock price was based on recent issuances. Expected life was based on the expiry date of the warrants as the Company did not have historical exercise data of such warrants. March 31, 2024 Stock price $ 0.07 Risk-free interest rate 5.26 % Expected life 5 Years Expected dividend rate 0 Expected volatility 180.773 % Continuity of the Company’s common stock purchase warrants issued and outstanding is as follows: Number of Warrants Weighted Average Exercise Price Outstanding, June 30, 2023 4,500,000 $ 0.25 Granted 10,671,740 0.25 Exercised - - Expired - - Outstanding, March 31, 2024 9,000,000 $ 0.13 Grant Date Number Outstanding Number Exercisable Exercise Price Weighted Average Life (Years) Expiry Date July 12, 2022 500,000 500,000 0.05 4.97 March 19, 2027 July 15, 2022 250,000 250,000 0.05 4.97 March 19, 2027 July 18, 2022 250,000 250,000 0.05 4.97 March 19, 2027 October 13, 2022 500,000 500,000 0.05 4.97 March 19, 2027 October 13, 2022 250,000 250,000 0.05 4.97 March 19, 2027 October 13, 2022 250,000 250,000 0.05 4.97 March 19, 2027 March 12, 2023 2,500,000 2,500,000 0.05 4.97 March 19, 2027 August 12, 2023 2,500,000 2,500,000 0.05 4.97 March 19, 2027 October 6, 2023 2,000,000 2,000,000 0.05 4.97 March 19, 2027 March 31, 2024 6,171,740 6,171,740 0.25 3.00 March 31, 2024 Total 15,171,740 15,171,740 0.13 4.17 As of March 31, 2024, the weighted average remaining contractual life of warrants outstanding was 4.17 years with an intrinsic value of $-. The exercise price for 9,000,000 warrants related to notes payable were re-priced to $0.05 during the nine months ended March 31, 2024. Stock Options On December 8, 2021, the Board of Directors of the Company approved the adoption of the 2021 Equity Compensation Plan (the “Equity Compensation Plan”) to provide employees, certain consultants and advisors who perform services for the Company , The following is a continuity schedule for the Company’s outstanding non-qualified stock options: Number of options Weighted Average Exercise Price Outstanding, June 30, 2023 6,000,000 $ 0.65 Granted - - Exercised - - Cancelled - - Outstanding, March 31, 2024 6,000,000 $ 0.65 As of December 31, 2023, the Company had the following stock options outstanding: Grant Date Number Outstanding Number Exercisable Exercise Price Weighted Average Life (Years) Expiry Date January 3, 2022 125,000 50,000 $ 0.65 7.77 January 3, 2032 January 4, 2022 5,750,000 2,300,000 0.65 7.77 January 4, 2032 March 1, 2023 125,000 50,000 0.65 7.77 January 4, 2032 Total 6,000,000 1,200,000 $ 0.65 7.77 During the nine months ended March 31, 2024, the Company recorded $493,410 as share-based compensation relating to the non-qualified stock options with an intrinsic value of $0. $2,169,515 has been recorded as share-based compensation relating to the outstanding options to date. The remaining $723,175 will be recorded as share-based compensation over the remaining vesting periods of the options. There were no options granted during the nine months ended March 31, 2024. Performance Stock Units On December 8, 2021, the Board of Directors of the Company approved the adoption of the 2021 Equity Compensation Plan (the “Equity Compensation Plan”) to provide employees, certain consultants and advisors who perform services for the Company , Each unit represents one common share: Number of Performance Units Vesting Conditions Expiry Dates - Market capitalization of the Company reaches $25 million December 31, 2026 900,000 Market capitalization of the Company reaches $50 million December 31, 2026 900,000 Market capitalization of the Company reaches $75 million December 31, 2026 900,000 Market capitalization of the Company reaches $100 million December 31, 2026 The following is a continuity schedule for the Company’s outstanding performance stock units: Number of Performance Units Weighted Average Exercise Price Outstanding, June 30, 2023 2,700,000 $ - Granted - - Exercised - - Forfeited or cancelled - - Outstanding, March 31, 2024 2,700,000 $ - As of March 31, 2024, the Company had the following performance units outstanding: Grant Date Number Outstanding Number Exercisable Exercise Price Weighted Average Life (Years) Expiry Date March 8, 2022 2,700,000 - USD $0.00 3.01 December 31, 2026 Total 2,700,000 - USD $0.00 3.01 During the nine months ended March 31, 2024, the Company recorded $226,034 as share-based compensation relating to the issuance of the performance units. $1,114,487 has been recorded as share-based compensation relating to the outstanding performance units to date. The remaining $199,513 will be recorded as share-based compensation over the remaining life of the units.

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	9 Months Ended
	Mar. 31, 2024
COMMITMENTS AND CONTINGENCIES
COMMITMENTS AND CONTINGENCIES	NOTE 10 – COMMITMENTS AND CONTINGENCIES The Company leases its corporate office located at 8565 S. Eastern Ave. #150, Las Vegas, Nevada. The initial lease term is for 12 months commencing on September 8, 2019 after which the term is on a month-to-month basis. After the initial term, the Company may cancel the lease agreement at any time by providing 30 days written notice. The Company has elected the short-term lease practical expedient of 12 months and has not recorded a lease.

INCOME TAXES

INCOME TAXES	9 Months Ended
	Mar. 31, 2024
INCOME TAXES
INCOME TAXES	NOTE 11 – INCOME TAXES As of March 31, 2024, the Company was in a loss position; therefore, no deferred tax liability was recognized related to the undistributed earnings subject to withholding tax. Net operating loss carry forward of the Company, approximated $8,082,775 (March 31, 2023 - $3,406,686) for the nine months ended March 31, 2024. The net operating loss carry forwards are available to be utilized against future taxable income for years through calendar year 2043. In assessing the reliability of deferred income tax assets, management considers whether it is more likely than not that some portion or all of the deferred income tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled projected future taxable income, and tax planning strategies in making this assessment.

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	9 Months Ended
	Mar. 31, 2024
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS	NOTE 12 – SUBSEQUENT EVENTS Through May 6, 2024, the Company completed a private placement whereby a total of 4,622,000 common shares were sold for cash at a price of $0.05 per share. On April 23, 2024, the Company issued 400,000 shares at a price of $0.165 per share to a non-related party in exchange for services.

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	9 Months Ended
	Mar. 31, 2024
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Preparation	The accompanying financial statements have been prepared to present the balance sheets, the statements of operations, statements of changes in shareholders’ equity and statements of cash flows of the Company for the nine months ended March 31, 2024 and 2023 and have been prepared in accordance with US GAAP.
Use of Estimates	In preparing financial statements in conformity with US GAAP, management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the dates of the financial statements, as well as the reported amounts of revenues and expenses during the reporting periods. Management makes these estimates using the best information available at the time the estimates are made. However, actual results could differ materially from those estimates.
Reclassification	Certain prior period amounts have been reclassified to conform to current period presentation.
Concentrations of Credit Risk	Financial instruments that potentially subject the Company to significant concentrations of credit risk consist principally of cash and accounts receivable. As of March 31, 2024, substantially all of the Company’s cash was held by major financial institutions located in the United States, which management believes are of high credit quality. With respect to accounts receivable, the Company extended credit based on an evaluation of the customer’s financial condition. The Company generally did not require collateral for accounts receivable and maintained an allowance for doubtful accounts of accounts receivable if necessary.
Cash	Cash consists of cash held at major financial institutions and is subject to insignificant risk of changes in value.
Receivables and Allowance for Doubtful Accounts	Trade accounts receivable are recorded at net realizable value and do not bear interest. No allowance for doubtful accounts was made during the nine months ended March 31, 2024 and 2023, based on management’s best estimate of the amount of probable credit losses in accounts receivable. The Company evaluates its allowance for doubtful accounts based upon knowledge of its customers and their compliance with credit terms. The evaluation process includes a review of customers’ accounts on a regular basis. The review process evaluates all account balances with amounts outstanding for more than 60 days and other specific amounts for which information obtained indicates that the balance may be uncollectible. As of March 31, 2024 and 2023, there was no allowance for doubtful accounts and the Company does not have any off-balance-sheet credit exposure related to its customers.
Software	Software is stated at cost less accumulated amortization and is depreciated using the straight-line method over the estimated useful life of the asset. The estimated useful life of the asset is 5 years. During the three months ended March 31, 2024, all development costs were expensed as incurred as management determined the costs were associated with minor updates and upgrades that did not impact the overall carrying value of the underlying software.
Leases	The Company determines if an arrangement is a lease at inception. Operating and financing right-of-use assets and lease liabilities are included on the balance sheet. Right-of-use assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Right-of-use assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. The Company uses its incremental borrowing rate, based on the information available at the commencement date, in determining the present value of future lease payments. Right-of-use assets include any prepaid lease payments and exclude any lease incentives and initial direct costs incurred. Operating lease expenses are recognized on a straight-line basis over the term of the lease, consisting of interest accrued on the lease liability and depreciation of the right-of-use asset. The lease terms may include options to extend or terminate the lease is it is reasonably certain the Company will exercise that option. The Company leases its corporate office located at 8565 S. Eastern Ave. #150, Las Vegas, Nevada. The initial lease term is for 12 months commencing on September 8, 2019 after which the term is on a month-to-month basis. After the initial term, the Company may cancel the lease agreement at any time by providing 30 days written notice. The Company has elected the short-term lease practical expedient of 12 months and has not recorded a lease.
Fair Value of Financial Instruments	Accounting Standards Codification (“ASC”) 820 “Fair Value Measurements and Disclosures”, adopted January 1, 2008, defines fair value, establishes a three-level valuation hierarchy for disclosures of fair value measurement and enhances disclosure requirements for fair value measures. The Company’s financial instruments include cash, current receivables and payables. These financial instruments are measured at their respective fair values. The three levels are defined as follows: Level 1 - inputs to the valuation methodology are quoted prices for identical assets or liabilities in active markets. Level 2 - inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the assets or liability, either directly or indirectly, for substantially the full term of the financial instruments. Level 3 - inputs to the valuation methodology are unobservable and significant to the fair value. For cash, accounts receivable, accounts payable and accrued liabilities and due to related parties, it is management’s opinion that the carrying values are a reasonable estimate of fair value because of the short period of time between the origination of such instruments and their expected realization and if applicable, their stated interest rate approximates current rates available. For convertible debts, the carrying values, excluding any unamortized discounts, approximate the respective fair value. The convertible debts have been discounted to reflect their net present value as of September 30, 2023. The carrying values of embedded conversion features not considered to be derivative instruments were determined by allocating the remaining carrying value of the convertible debt after deducting the estimated carrying value of the liability portion. Estimating fair value for warrants require determining the most appropriate valuation model which is dependent on the terms and conditions of the grant. This estimate requires determining the most appropriate inputs to the valuation model including the expected life of the warrant, volatility, dividend yield, and rate of forfeitures and making assumptions about them.
Revenue Recognition	We derive revenue from the sale of Tego software subscriptions, and Tego TI intelligence feed subscriptions. We enter into contracts with customers that include promises to transfer various products and services, which are generally capable of being distinct and accounted for as separate performance obligations. Revenue is recognized when the promised goods or services are transferred to customers, in an amount that reflects the consideration allocated to the respective performance obligation. The following table shows our revenue by source for the periods indicated: Three Months Ended March 31, Nine Months Ended March 31, 2024 2023 2024 2023 Software $ 14,231 $ - $ 24,962 $ - $ 14,231 $ - $ 24,962 $ -
Nature of Products	Our cloud-based offerings include Tego cyber threat detection and correlation software, and threat intelligence data feeds, developed for use by organizations from small to large. These cloud-based offerings provide customers with the right to use the hosted software over the contract period without taking possession of the software and are billed on either a subscription or consumption basis. Revenue related to our cloud-based offerings that are billed on a subscription basis is recognized ratably over the contract period. Revenue related to online offerings that are billed on a consumption basis is recognized when the customer consumes the related service.
Deferred Revenue	We record deferred revenue when we have entered into a contract with a customer and cash payments are received or due prior to transfer of control or satisfaction of the related performance obligation.
Income Taxes	The Company uses the asset and liability method of accounting for income taxes pursuant to ASC 740 “Income Taxes”. ASC 740 requires an asset and liability approach for financial accounting and reporting for income taxes and allows recognition and measurement of deferred tax assets based upon the likelihood of realization of tax benefits in future years. Under the asset and liability approach, deferred taxes are provided for the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Valuation allowances are provided for deferred tax assets if it is more likely than not these items will either expire before the Company is able to realize their benefits, or that future deductibility is uncertain. The provision for income taxes represents current taxes payable net of the change during the period in deferred tax assets and liabilities.
Earnings (Loss) per Share	Basic earnings (loss) per share is computed by dividing income (loss) available to common shareholders by the weighted-average number of common shares outstanding during the period. Diluted earnings (loss) per share is computed similar to basic earnings (loss) per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. If applicable, diluted earnings (loss) per share assume the conversion, exercise or issuance of all common stock instruments unless the effect is to reduce a loss or increase earnings (loss) per share. Dilutive securities are not included in the weighted average number of shares when inclusion would be anti-dilutive. The following table summarizes the securities outstanding and exercisable, (regardless of exercise price) as of March 31, 2024 and 2023 that were excluded from the diluted net loss per share calculation because the effect of including these potential shares was antidilutive due to the Company’s net loss. 2024 2023 Potentially dilutive common share equivalents Options 1,200,000 1,200,000 Warrants 15,171,740 3,914,246 Performance Stock Units 2,700,000 4,000,000 Potentially dilutive shares outstanding 19,071,740 9,114,246
Recently Issued Accounting Pronouncements	In August 2020, the FASB issued ASU 2020-06 , Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40)—Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity. Derivatives and Hedging Derivatives and Hedging—Contracts in Entity’s Own Equity Management does not believe that any recently issued, but not yet effective, accounting standards could have a material effect on the accompanying financial statements. As new accounting pronouncements are issued, we will adopt those that are applicable under the circumstances.

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	9 Months Ended
	Mar. 31, 2024
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Potentially dilutive common share equivalents	Three Months Ended March 31,   Nine Months Ended March 31,    2024  2023  2024  2023              Software $14,231  $-  $24,962  $-                    $14,231  $-  $24,962  $-
Revenue by source	2024 2023 Potentially dilutive common share equivalents Options 1,200,000 1,200,000 Warrants 15,171,740 3,914,246 Performance Stock Units 2,700,000 4,000,000 Potentially dilutive shares outstanding 19,071,740 9,114,246

NOTES PAYABLE (Tables)

NOTES PAYABLE (Tables)	9 Months Ended
	Mar. 31, 2024
NOTES PAYABLE
Schedule Of Notes payable	Reference Effective Date Annual Interest Rate Maturity Date Principal Outstanding March 31, 2024 Principal Outstanding June 30, 2023 (a) 7/12/22 15 % 6/30/24 $ 335,000 $ 299,926 (b) 7/15/22 15 % 6/30/24 192,500 149,963 (c) 7/18/22 15 % 6/30/24 192,500 149,963 (d) 10/13/22 10 % 6/30/24 150,000 145,923 (e) 10/13/22 10 % 6/30/24 75,000 72,960 (f) 10/13/22 10 % 6/30/24 75,000 72,960 $ 1,020,000 $ 891,694

COMMON SHARES (Tables)

COMMON SHARES (Tables)	9 Months Ended
	Mar. 31, 2024
COMMON SHARES
Schedule of historical exercise data	March 31, 2024 Stock price $ 0.07 Risk-free interest rate 5.26 % Expected life 5 Years Expected dividend rate 0 Expected volatility 180.773 %
Schedule of common stock purchase warrants	Number of Warrants Weighted Average Exercise Price Outstanding, June 30, 2023 4,500,000 $ 0.25 Granted 10,671,740 0.25 Exercised - - Expired - - Outstanding, March 31, 2024 9,000,000 $ 0.13
Schedule of stock purchase warrants outstanding	Grant Date Number Outstanding Number Exercisable Exercise Price Weighted Average Life (Years) Expiry Date July 12, 2022 500,000 500,000 0.05 4.97 March 19, 2027 July 15, 2022 250,000 250,000 0.05 4.97 March 19, 2027 July 18, 2022 250,000 250,000 0.05 4.97 March 19, 2027 October 13, 2022 500,000 500,000 0.05 4.97 March 19, 2027 October 13, 2022 250,000 250,000 0.05 4.97 March 19, 2027 October 13, 2022 250,000 250,000 0.05 4.97 March 19, 2027 March 12, 2023 2,500,000 2,500,000 0.05 4.97 March 19, 2027 August 12, 2023 2,500,000 2,500,000 0.05 4.97 March 19, 2027 October 6, 2023 2,000,000 2,000,000 0.05 4.97 March 19, 2027 March 31, 2024 6,171,740 6,171,740 0.25 3.00 March 31, 2024 Total 15,171,740 15,171,740 0.13 4.17
Schedule of Company's outstanding non-qualified	Number of options Weighted Average Exercise Price Outstanding, June 30, 2023 6,000,000 $ 0.65 Granted - - Exercised - - Cancelled - - Outstanding, March 31, 2024 6,000,000 $ 0.65
Schedule of stock options outstanding	Grant Date Number Outstanding Number Exercisable Exercise Price Weighted Average Life (Years) Expiry Date January 3, 2022 125,000 50,000 $ 0.65 7.77 January 3, 2032 January 4, 2022 5,750,000 2,300,000 0.65 7.77 January 4, 2032 March 1, 2023 125,000 50,000 0.65 7.77 January 4, 2032 Total 6,000,000 1,200,000 $ 0.65 7.77
Schedule of performance stock units	Number of Performance Units Vesting Conditions Expiry Dates - Market capitalization of the Company reaches $25 million December 31, 2026 900,000 Market capitalization of the Company reaches $50 million December 31, 2026 900,000 Market capitalization of the Company reaches $75 million December 31, 2026 900,000 Market capitalization of the Company reaches $100 million December 31, 2026
Schedule for the Company's outstanding performance stock units:	Number of Performance Units Weighted Average Exercise Price Outstanding, June 30, 2023 2,700,000 $ - Granted - - Exercised - - Forfeited or cancelled - - Outstanding, March 31, 2024 2,700,000 $ -
Schedule for the Company's outstanding warrants:	Grant Date Number Outstanding Number Exercisable Exercise Price Weighted Average Life (Years) Expiry Date March 8, 2022 2,700,000 - USD $0.00 3.01 December 31, 2026 Total 2,700,000 - USD $0.00 3.01

GOING CONCERN UNCERTAINTY (Deta

GOING CONCERN UNCERTAINTY (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023
GOING CONCERN UNCERTAINTY
Working capital	$ (1,452,247)		$ (1,452,247)
Net loss for the period	$ (1,062,163)	$ (4,854,357)	(7,389,314)	$ (7,499,635)
Net cash provided by used in operating activities			$ (673,962)	$ (1,189,218)

SUMMARY OF SIGNIFICANT ACCOUN_4

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)	3 Months Ended		9 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023
Revenue by source	$ 14,231	$ 0	$ 24,962	$ 0
Software [Member]
Revenue by source	$ 14,231	$ 0	$ 24,962	$ 0

SUMMARY OF SIGNIFICANT ACCOUN_5

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1) - shares	9 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Options	1,200,000	1,200,000
Warrants	15,171,740	3,914,246
Performance Stock Units	2,700,000	4,000,000
Potentially dilutive shares outstanding	19,071,740	9,114,246

SUMMARY OF SIGNIFICANT ACCOUN_6

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)	9 Months Ended
	Mar. 31, 2024 USD ($)
Allowance for doubtful accounts	$ 0
Initial lease term	12 months
July 12, 2022 [Member] | Convertible Debt [Member]
Estimated useful life	5 years

SOFTWARE (Details Narrative)

SOFTWARE (Details Narrative)	9 Months Ended
	Mar. 31, 2024 USD ($)
SOFTWARE
Impairment loss	$ 646,271

RELATED PARTY TRANSACTIONS (Det

RELATED PARTY TRANSACTIONS (Details Narrativess) - USD ($)	9 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Shannon Wilkinson
Management Fees	$ 80,504	$ 0
Gross Wages	15,000	90,000
Earl Johnson
Management Fees	4,500	0
Gross Wages	4,500	27,000
Robert Wilkinson
Management Fees	$ 47,500	$ 0

NOTES PAYABLE (Details)

NOTES PAYABLE (Details)	9 Months Ended
	Mar. 31, 2024 USD ($)
Note Payable outstanding, beginning balance	$ 891,694
Note Payable outstanding, ending balance	1,020,000
Notes Payable Two Member
Note Payable outstanding, beginning balance	$ 149,963
Effective Date	Jul. 15, 2022
Maturity date	Jun. 30, 2024
Annual Interest rate	15%
Note Payable outstanding, ending balance	$ 192,500
Notes Payable Three Member
Note Payable outstanding, beginning balance	$ 149,963
Effective Date	Jul. 18, 2022
Maturity date	Jun. 30, 2024
Annual Interest rate	15%
Note Payable outstanding, ending balance	$ 192,500
Notes Payable Four Member
Note Payable outstanding, beginning balance	$ 145,923
Effective Date	Oct. 13, 2022
Maturity date	Jun. 30, 2024
Annual Interest rate	10%
Note Payable outstanding, ending balance	$ 150,000
Notes Payable Five Member
Note Payable outstanding, beginning balance	$ 72,960
Effective Date	Oct. 13, 2022
Maturity date	Jun. 30, 2024
Annual Interest rate	10%
Note Payable outstanding, ending balance	$ 75,000
Notes Payable Six Member
Note Payable outstanding, beginning balance	$ 72,960
Effective Date	Oct. 13, 2022
Maturity date	Jun. 30, 2024
Annual Interest rate	10%
Note Payable outstanding, ending balance	$ 75,000
Notes Payable One Member
Note Payable outstanding, beginning balance	$ 299,926
Effective Date	Jul. 12, 2022
Maturity date	Jun. 30, 2024
Annual Interest rate	15%
Note Payable outstanding, ending balance	$ 335,000

NOTES PAYABLE (Details Narrativ

NOTES PAYABLE (Details Narratives) - USD ($)				1 Months Ended	9 Months Ended
	Oct. 13, 2022	Jul. 15, 2022	Jul. 12, 2022	Jul. 18, 2022	Mar. 31, 2024
Description of extensin fee of note obligations					The extension fees were paid by issuing 7,033,334 restricted shares and 5 year warrants to purchase 4,500,000 restricted common shares of the Company for $0.25 per share, and were expensed as they were deemed to be extinguishments of the original obligations under ASC 470-50. Additionally, the Company agreed to reduce the exercise price on the warrants to $0.05 and increase the notes payable balances by $170,000 as part of the extensions
Total Financing expenses					$ 4,520,357
July 12, 2022 [Member] | Convertible Debt [Member]
Convertible debt in exchange for cash			$ 300,000
Convertible debt in exchange for cash, fair value			270,000
Original issue discount			30,000
Additional cash proceeds			$ 27,500
Common shares issue			350,000
Common shares issue value			$ 178,500
Warrants issued			500,000
Warrant exercisable			$ 0.25
Fair value of warrant			$ 249,971
Convertible interest rate			10%
July 15, 2022 [Member] | Convertible Debt [Member]
Convertible debt in exchange for cash		$ 150,000
Convertible debt in exchange for cash, fair value		135,000
Original issue discount		15,000
Additional cash proceeds		$ 11,250
Common shares issue		175,000
Common shares issue value		$ 89,250
Warrants issued		250,000
Warrant exercisable		$ 0.25
Fair value of warrant		$ 124,984
Convertible interest rate		10%
July 18, 2022 [Member] | Convertible Debt [Member]
Convertible debt in exchange for cash				$ 150,000
Convertible debt in exchange for cash, fair value				135,000
Original issue discount				15,000
Additional cash proceeds				$ 11,250
Common shares issue				175,000
Common shares issue value				$ 89,250
Warrants issued				250,000
Warrant exercisable				$ 0.25
Fair value of warrant				$ 124,994
Convertible interest rate				10%
October 13, 2022 [Member] | Convertible Debt [Member]
Convertible debt in exchange for cash	$ 150,000
Convertible debt in exchange for cash, fair value	135,000
Original issue discount	15,000
Additional cash proceeds	$ 23,750
Common shares issue	416,667
Common shares issue value	$ 187,625
Warrants issued	500,000
Warrant exercisable	$ 0.25
Fair value of warrant	$ 220,526
Convertible interest rate	10%
Maturity date of agreement	Apr. 13, 2023
October 13, 2022 [Member] | Convertible Debt 1 [Member]
Convertible debt in exchange for cash	$ 75,000
Convertible debt in exchange for cash, fair value	67,500
Original issue discount	7,500
Additional cash proceeds	$ 5,625
Common shares issue	208,333
Common shares issue value	$ 93,812
Warrants issued	250,000
Warrant exercisable	$ 0.25
Fair value of warrant	$ 110,263
Convertible interest rate	10%
October 13, 2022 [Member] | Convertible Debt Two [Member]
Convertible debt in exchange for cash	$ 75,000
Convertible debt in exchange for cash, fair value	67,500
Original issue discount	7,500
Additional cash proceeds	$ 5,625
Common shares issue	208,333
Common shares issue value	$ 93,812
Warrants issued	250,000
Warrant exercisable	$ 0.25
Fair value of warrant	$ 110,263
Convertible interest rate	10%
Maturity date of agreement	Apr. 13, 2023

COMMON SHARES (Details)

COMMON SHARES (Details)	9 Months Ended
	Mar. 31, 2024 $ / shares
COMMON SHARES
Stock price	$ 0.07
Risk-free interest rate	5.26%
Expected life	5 months
Expected dividend rate	0%
Expected volatility	180%

COMMON SHARES (Details 1)

COMMON SHARES (Details 1)	9 Months Ended
	Mar. 31, 2024 $ / shares shares
COMMON SHARES
Number Of Warrants Outstanding, Beginning | shares	4,500,000
Number Of Warrants Granted | shares	10,671,740
Number Of Warrants Outstanding,Ending Balance | shares	9,000,000
Weighted Average Exercise Price Outstanding, Beginning	$ 0.25
Weighted Average Exercise Price Granted	0.25
Weighted Average Exercise Price Exercised	0
Weighted Average Exercise Price Expired	0
Weighted Average Exercise Price Outstanding, ending	$ 0.13

COMMON SHARES (Details 2)

COMMON SHARES (Details 2)	9 Months Ended
	Mar. 31, 2024 $ / shares shares
Weighted Average life	7 years 9 months 7 days
Total Member
Weighted Average life	4 months 5 days
Number of Warrants outstanding	15,171,740
Exercise | $ / shares	$ 0.13
Number of Warrants Exercisable	15,171,740
July 12, 2022 [Member]
Weighted Average life	4 years 11 months 19 days
Number of Warrants outstanding	500,000
Exercise | $ / shares	$ 0.05
Number of Warrants Exercisable	500,000
Expiry Date	March 19, 2027
July 15, 2022 [Member]
Weighted Average life	4 years 11 months 19 days
Number of Warrants outstanding	250,000
Exercise | $ / shares	$ 0.05
Number of Warrants Exercisable	250,000
Expiry Date	March 19, 2027
July 18, 2022 [Member]
Weighted Average life	4 years 11 months 19 days
Number of Warrants outstanding	250,000
Exercise | $ / shares	$ 0.05
Number of Warrants Exercisable	250,000
Expiry Date	March 19, 2027
October 13, 2022, One [Member]
Weighted Average life	4 years 11 months 19 days
Number of Warrants outstanding	500,000
Exercise | $ / shares	$ 0.05
Number of Warrants Exercisable	500,000
Expiry Date	March 19, 2027
October 13, 2022, Two [Member]
Weighted Average life	4 years 11 months 19 days
Number of Warrants outstanding	250,000
Exercise | $ / shares	$ 0.05
Number of Warrants Exercisable	250,000
Expiry Date	March 19, 2027
October 13, 2022, Three [Member]
Weighted Average life	4 months 29 days
Number of Warrants outstanding	250,000
Exercise | $ / shares	$ 0.05
Number of Warrants Exercisable	250,000
Expiry Date	March 19, 2027
March 12, 2023, [Member]
Weighted Average life	4 months 29 days
Number of Warrants outstanding	2,500,000
Exercise | $ / shares	$ 0.05
Number of Warrants Exercisable	2,500,000
Expiry Date	March 19, 2027
August 12 2023 [Member]
Weighted Average life	4 years 11 months 19 days
Number of Warrants outstanding	2,500,000
Exercise | $ / shares	$ 0.05
Number of Warrants Exercisable	2,500,000
Expiry Date	March 19, 2027
October 6, 2023[Member]
Weighted Average life	4 months 29 days
Number of Warrants outstanding	2,000,000
Exercise | $ / shares	$ 0.05
Number of Warrants Exercisable	2,000,000
Expiry Date	March 19, 2027
March 31,2024 [Member]
Weighted Average life	3 months
Number of Warrants outstanding	6,171,740
Exercise | $ / shares	$ 0.25
Number of Warrants Exercisable	6,171,740
Expiry Date	March 31, 2024

COMMON SHARES (Details 3)

COMMON SHARES (Details 3)	9 Months Ended
	Mar. 31, 2024 $ / shares shares
COMMON SHARES
Number Of Warrants Outstanding, Ending Balance | shares	6,000,000
Weighted Average Exercise Price Outstanding, Beginning Balance	$ 0.65
Weighted Average Exercise Price Granted	0
Weighted Average Exercise Price Cancelled	0
Weighted Average Exercise Price Exercised	0
Weighted Average Exercise Price Outstanding, Ending Balance	$ 0.65
Number Of Warrants Outstanding, Beginning | shares	6,000,000

COMMON SHARES (Details 4)

COMMON SHARES (Details 4) - $ / shares	9 Months Ended
	Mar. 31, 2024	Dec. 31, 2023
Number of option outstanding		6,000,000
Weighted Average life	7 years 9 months 7 days
Exercise		$ 0.65
Number of option Exercisable		1,200,000
January 3, 2022 [Member]
Number of option outstanding		125,000
Weighted Average life	7 years 9 months 7 days
Exercise		$ 0.65
Number of option Exercisable		50,000
Expiry Date	January 3, 2032
January 4, 2022 [Member]
Number of option outstanding		5,750,000
Weighted Average life	7 years 9 months 7 days
Exercise		$ 0.65
Number of option Exercisable		2,300,000
Expiry Date	January 4, 2032
March 1, 2023 [Member]
Number of option outstanding		125,000
Weighted Average life	7 years 9 months 7 days
Exercise		$ 0.65
Number of option Exercisable		50,000
Expiry Date	January 4, 2032

COMMON SHARES (Details 5)

COMMON SHARES (Details 5) - directors, officers and certain key consultants	9 Months Ended
	Mar. 31, 2024 shares
Performance Stock Units 1
Number of Performance Units	900,000
Vesting Conditions of Performance Units	Market capitalization of the Company reaches $50 million
Expiry Dates Performance Stock Units	December 31, 2026
Performance Stock Units 2
Number of Performance Units	900,000
Vesting Conditions of Performance Units	Market capitalization of the Company reaches $75 million
Expiry Dates Performance Stock Units	December 31, 2026
Performance Stock Units 3
Number of Performance Units	900,000
Vesting Conditions of Performance Units	Market capitalization of the Company reaches $100 million
Expiry Dates Performance Stock Units	December 31, 2026
Performance Stock Units
Vesting Conditions of Performance Units	Market capitalization of the Company reaches $25 million
Expiry Dates Performance Stock Units	December 31, 2026

COMMON SHARES (Details 6)

COMMON SHARES (Details 6)	9 Months Ended
	Mar. 31, 2024 $ / shares shares
COMMON SHARES
Number of Warrants Granted | shares	0
Number of Warrants Exercised | shares	0
Number of Warrants Forfeited or cancelled | shares	0
Weighted Average Exercise Price Beginning balance | $ / shares	$ 0
Number of Warrants Outstanding,Ending | shares	2,700,000
Weighted Average Exercise Price Granted | $ / shares	$ 0
Weighted Average Exercise Price Released | $ / shares	0
Weighted Average Exercise Price Forfeited or Cancelled | $ / shares	0
Weighted Average Exercise Price Ending, Balance | $ / shares	$ 0
Number of Warrants Outstanding, beginning | shares	2,700,000

COMMON SHARES (Details 7)

COMMON SHARES (Details 7)	9 Months Ended
	Mar. 31, 2024 $ / shares shares
Number of option outstanding | shares	2,700,000
Exercise Price | $ / shares	$ 0
Weighted Average Life (Years)	3 months
March 8, 2022 [Member]
Number of option outstanding | shares	2,700,000
Exercise Price | $ / shares	$ 0
Weighted Average Life (Years)	3 months
Expiry date	December 31, 2026

COMMON SHARES (Details Narrativ

COMMON SHARES (Details Narrative) - USD ($)	3 Months Ended	9 Months Ended
	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023	Jun. 30, 2023
Common stock, authorized		100,000,000			100,000,000
Share-based compensation	$ 331,051	$ 1,175,369	$ 1,536,980
Common stock, par value		$ 0.001			$ 0.001
Weighted average remaining contractual life of warrants outstanding		4 months 5 days
Common stock debt settlement		1,271,740
Common stock value		$ 63,589
Warrant Shares		9,000,000
Common stock value		$ 71,068			$ 47,343
Warrants intrinsic value		$ 0.05
Common stock, issued		71,068,356			47,343,282
Common stock, outstanding		71,068,356			47,343,282
Investors [Member]
Common stock, issued		9,770,000
Cash proceeds		$ 612,000
Common Stocks [Member]
Common stock, authorized				100,000,000
Common stock, par value				$ 0.001
Stock issued for services		2,900,000
Common stock value		$ 612,749
Common stock, issued				59,446,616
Common stock, outstanding				59,446,616
non Qualified Stock [Member]
Share-based compensation		$ 493,410
Description of non qualified stock options		2,169,515 has been recorded as share-based compensation relating to the outstanding options to date. The remaining $723,175 will be recorded as share-based compensation over the remaining vesting periods of the options
Intrinsic value		$ 0
Performance Stock Unit [Member]
Share-based compensation		$ 226,034
Description of performance stock units		1,114,487 has been recorded as share-based compensation relating to the outstanding performance units to date. The remaining $199,513 will be recorded as share-based compensation over the remaining life of the units
Agreement [Member]
Share issued during period		2,750,000
Extension Agreement [Member]
Share-based compensation		$ 681,959
Total value		$ 2,356,705
Stock issued for services		7,033,334

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Details Narrative)	Sep. 08, 2019
COMMITMENTS AND CONTINGENCIES
Initial lease term	12 months

INCOME TAXES (Details Narrative

INCOME TAXES (Details Narrative) - USD ($)	Mar. 31, 2024	Dec. 31, 2023
INCOME TAXES
Net operating loss carry forward	$ 3,406,686	$ 8,082,775

SUBSEQUENT EVENTS (Details Narr

SUBSEQUENT EVENTS (Details Narrative) - $ / shares	May 06, 2024	Apr. 23, 2024	Mar. 31, 2024	Jun. 30, 2023
Common shares			71,068,356	47,343,282
Subsequent Event [Member]
Common stock par value	$ 0.05	$ 0.165
Common shares	4,622,000	400,000